Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription 05.11.2018 1 Acta Haematol 5 Am J Hematol 4 Ann Hematol 2 Biochem Biophys Res Commun 1 Bone Marrow Transplant 1 Genes Chromosomes Cancer 6 Int J Hematol 1 Leuk Lymphoma 1 Leuk Res 1 Oncol Rep

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Haematol

1. ABRUZZESE E, Trawinska MM, Neri B, Bondanini F, et al
   Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
   Acta Haematol. 2018;140:231-233.
   PubMed     Text format    
   
   

   
   Am J Hematol

2. LOEFF FC, Rijs K, van Egmond EHM, Zoutman WH, et al
   Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression.
   Am J Hematol. 2018 Oct 29. doi: 10.1002/ajh.25337.
   PubMed     Text format     Abstract available
   
   
3. KONUMA T, Harada K, Yamasaki S, Mizuno S, et al
   Upfront allogeneic HCT vs remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: a propensity score matched analysis.
   Am J Hematol. 2018 Oct 29. doi: 10.1002/ajh.25336.
   PubMed     Text format     Abstract available
   
   
4. JELINEK T, Mihalyova J, Kascak M, Duras J, et al
   Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t[11;14].
   Am J Hematol. 2018 Oct 29. doi: 10.1002/ajh.25331.
   PubMed     Text format    
   
   
5. LITZOW MR, Wang XV, Carroll MP, Karp JE, et al
   A Randomized Trial of Three Novel Regimens for Recurrent Acute Myeloid Leukemia Demonstrates the Continuing Challenge of Treating this Difficult Disease.
   Am J Hematol. 2018 Oct 29. doi: 10.1002/ajh.25333.
   PubMed     Text format     Abstract available
   
   
6. BAHASHWAN S, Molucon-Chabrot C, Hermet E, Ravinet A, et al
   Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia.
   Am J Hematol. 2018 Oct 29. doi: 10.1002/ajh.25332.
   PubMed     Text format    
   
   

   
   Ann Hematol

7. LI Y, Shao H, Fu B
   Coexistence of t(5;17)/NPM1-RARA and t(9;22)/BCR-ABL1 in chronic myeloid leukemia at initial diagnosis.
   Ann Hematol. 2018 Oct 30. pii: 10.1007/s00277-018-3537.
   PubMed     Text format    
   
   
8. ZAPRAZNA K, Reblova K, Svobodova V, Radova L, et al
   Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.
   Ann Hematol. 2018 Oct 27. pii: 10.1007/s00277-018-3520.
   PubMed     Text format     Abstract available
   
   
9. BARON F, Stevens-Kroef M, Kicinski M, Meloni G, et al
   Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
   Ann Hematol. 2018;97:1785-1795.
   PubMed     Text format     Abstract available
   
   
10. BARONI F, Marraccini C, Merolle L, Piccagli V, et al
    Red blood cells metabolome changes upon treatment with different X-ray irradiation doses.
    Ann Hematol. 2018;97:1909-1917.
    PubMed     Text format     Abstract available
    
    

    
    Biochem Biophys Res Commun

11. WANG F, Cao LX, Luo ZY, Liao P, et al
    LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia.
    Biochem Biophys Res Commun. 2018 Oct 23. pii: S0006-291X(18)31952.
    PubMed     Text format     Abstract available
    
    
12. HE B, Chang Y, Yang C, Zhang Z, et al
    Adenylate cyclase 7 regulated by miR-192 promotes ATRA-induced differentiation of acute promyelocytic leukemia cells.
    Biochem Biophys Res Commun. 2018 Oct 23. pii: S0006-291X(18)32291.
    PubMed     Text format     Abstract available
    
    

    
    Bone Marrow Transplant

13. GIEBEL S, Marks DI, Boissel N, Baron F, et al
    Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute L
    Bone Marrow Transplant. 2018 Nov 1. pii: 10.1038/s41409-018-0373.
    PubMed     Text format     Abstract available
    
    

    
    Genes Chromosomes Cancer

14. LUPO PJ, Brown AL, Arroyo VM, Kamdar KY, et al
    DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
    Genes Chromosomes Cancer. 2018 Nov 1. doi: 10.1002/gcc.22701.
    PubMed     Text format     Abstract available
    
    

    
    Int J Hematol

15. HOSOI H, Mushino T, Nishikawa A, Hashimoto H, et al
    Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration.
    Int J Hematol. 2018;107:717-719.
    PubMed     Text format    
    
    
16. EVERS D, Bar BMAM, Gotthardt M, van der Velden WJFM, et al
    Activity of decitabine in pericardial myeloid sarcoma.
    Int J Hematol. 2018;108:121-122.
    PubMed     Text format    
    
    
17. DOTSON JL, Jamil MO
    Successful treatment of cytarabine-related neurotoxicity with corticosteroids, a case series.
    Int J Hematol. 2018;108:554-557.
    PubMed     Text format     Abstract available
    
    
18. TAGA T, Imamura T, Nakashima K, Maeda N, et al
    Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan.
    Int J Hematol. 2018;108:438-442.
    PubMed     Text format     Abstract available
    
    
19. WOLTERS R, Curry CV
    Conspicuous activated lymphocytic proliferation associated with cytokine-release syndrome after CAR T-cell therapy.
    Int J Hematol. 2018;108:461-462.
    PubMed     Text format    
    
    
20. KAMACHI K, Shindo T, Miyahara M, Kitaura K, et al
    Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution.
    Int J Hematol. 2018 Oct 27. pii: 10.1007/s12185-018-2552.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

21. POPP HD, Flach J, Brendel S, Ruppenthal S, et al
    Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Leuk Lymphoma. 2018 Oct 31:1-10. doi: 10.1080/10428194.2018.1498494.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Res

22. ARABANIAN LS, Johansson P, Staffas A, Nilsson T, et al
    The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
    Leuk Res. 2018 Oct 13. pii: S0145-2126(18)30430.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

23. PANG X, Wang Y, Zhang S, Tan Z, et al
    Altered susceptibility to apoptosis and Nglycan profiles of hematopoietic KG1a cells following coculture with bone marrowderived stromal cells under hypoxic conditions.
    Oncol Rep. 2018;40:1477-1486.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: